NASDAQ: DTILPrecision Biosciences Inc Stock Ownership - Who owns Precision Biosciences?
Insider buying vs selling
Have Precision Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John Alexander Kelly | Chief Financial Officer | 2025-07-03 | 14,827 | $4.26 | $63.16kSell |
| Melinda Brown | Director | 2025-06-25 | 1,682 | $4.14 | $6.96kBuy |
| Kevin Buehler | Director | 2025-06-25 | 5,076 | $4.16 | $21.12kBuy |
| Melinda Brown | Director | 2025-03-26 | 1,839 | $4.75 | $8.74kBuy |
| Kevin Buehler | Director | 2025-03-26 | 4,523 | $4.67 | $21.12kBuy |
| Geno J. Germano | Director | 2025-03-25 | 3,250 | $5.30 | $17.23kBuy |
| Michael Amoroso | President and CEO | 2025-03-24 | 964 | $5.56 | $5.36kSell |
| J. Jefferson Smith | Chief Research Officer | 2025-03-04 | 154 | $4.91 | $756.14Sell |
| Dario Scimeca | General Counsel and Secretary | 2025-03-04 | 272 | $4.91 | $1.34kSell |
| Dario Scimeca | General Counsel and Secretary | 2025-01-22 | 8,928 | $4.79 | $42.77kSell |
DTIL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when DTIL insiders and whales buy or sell their stock.
DTIL Shareholders
What type of owners hold Precision Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Pharma Ag Novartis | 111.90% | 12,407,440 | $60.80M | Insider |
| Venbio Global Strategic Fund LP | 38.47% | 4,265,141 | $20.90M | Insider |
| Derek Jantz | 36.57% | 4,055,174 | $19.87M | Insider |
| Fmr LLC | 33.71% | 3,738,248 | $18.32M | Insider |
| Matthew R. Kane | 18.26% | 2,024,438 | $9.92M | Insider |
| Bleichroeder LP | 9.69% | 1,075,000 | $5.27M | Institution |
| Lynx1 Capital Management LP | 9.34% | 1,036,051 | $5.08M | Institution |
| Tang Capital Management LLC | 5.89% | 653,649 | $3.20M | Institution |
| Vanguard Group Inc | 3.66% | 405,354 | $1.99M | Institution |
| Acadian Asset Management LLC | 2.04% | 225,937 | $1.11M | Institution |
DTIL vs Biotech Stocks
Precision Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.